First case of DRESS syndrome caused by apalutamide, a novel oral androgen receptor antagonist

2021 ◽  
Author(s):  
Océane Ducharme ◽  
Paola Sanchez‐Pena ◽  
Anne Pham‐Ledard ◽  
Marie Beylot‐Barry ◽  
Brigitte Milpied
Keyword(s):  
Androgen Receptor ◽  
Receptor Antagonist ◽  
Dress Syndrome ◽  
Androgen Receptor Antagonist ◽  
First Case

Computational and Functional Analysis of the Androgen Receptor Antagonist Atraric Acid and Its Derivatives

2013 ◽  
Vol 13 (5) ◽  
pp. 801-810 ◽  
Author(s):  
Maria Papaioannou ◽  
Annu A. Soderholm ◽  
Wei Hong ◽  
Yifan Dai ◽  
Julia Roediger ◽  
...  
Keyword(s):  
Functional Analysis ◽  
Androgen Receptor ◽  
Receptor Antagonist ◽  
Androgen Receptor Antagonist

Discovery of JNJ-63576253: A Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC)

2021 ◽  
Vol 64 (2) ◽  
pp. 909-924 ◽  
Author(s):  
Zhuming Zhang ◽  
Peter J. Connolly ◽  
Heng Keang Lim ◽  
Vineet Pande ◽  
Lieven Meerpoel ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Receptor Antagonist ◽  
Clinical Stage ◽  
Castration Resistant Prostate Cancer ◽  
Wild Type ◽  
Androgen Receptor Antagonist ◽  
Castration Resistant

scholarly journals Enzalutamide, an Androgen Receptor Antagonist, Enhances Myeloid Cell–Mediated Immune Suppression and Tumor Progression

2020 ◽  
Vol 8 (9) ◽  
pp. 1215-1227 ◽  
Author(s):  
Camila R. Consiglio ◽  
Olga Udartseva ◽  
Kimberly D. Ramsey ◽  
Chioma Bush ◽  
Sandra O. Gollnick
Keyword(s):  
Androgen Receptor ◽  
Tumor Progression ◽  
Receptor Antagonist ◽  
Immune Suppression ◽  
Myeloid Cell ◽  
Androgen Receptor Antagonist

Abstract PR09: TAS3681, a new type androgen receptor antagonist, suppresses ligand-independent AR activation through its AR downregulation activity

2015 ◽  
Author(s):  
Daisuke Kajiwara ◽  
Kazuhisa Minamiguchi ◽  
Masanao Seki ◽  
Hiroya Mizutani ◽  
Hiroki Aoyagi ◽  
...  
Keyword(s):  
Androgen Receptor ◽  
Receptor Antagonist ◽  
Androgen Receptor Antagonist ◽  
New Type

scholarly journals P01.068 The anti-tumor effect of androgen receptor antagonist on GBM may result, at least partially, through attenuation of CDK4 and CDC14a expression

2018 ◽  
Vol 20 (suppl_3) ◽  
pp. iii245-iii245
Author(s):  
N Zalcman ◽  
A Mordechai ◽  
A Lossos ◽  
I Lavon
Keyword(s):  
Androgen Receptor ◽  
Receptor Antagonist ◽  
Androgen Receptor Antagonist

The androgen receptor antagonist enzalutamide induces apoptosis, dysregulates the heat shock protein system, and diminishes the androgen receptor and estrogen receptor β1 expression in prostate cancer cells

2019 ◽  
Vol 120 (10) ◽  
pp. 16711-16722
Author(s):  
Alexander Abazid ◽  
Benedikt Martin ◽  
Anja Choinowski ◽  
Rhiannon V. McNeill ◽  
Lars‐Ove Brandenburg ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Estrogen Receptor ◽  
Androgen Receptor ◽  
Heat Shock ◽  
Heat Shock Protein ◽  
Receptor Antagonist ◽  
Cancer Cells ◽  
Prostate Cancer Cells ◽  
Protein System ◽  
Androgen Receptor Antagonist
Sign in / Sign up

Export Citation Format

Share Document